XML 82 R66.htm IDEA: XBRL DOCUMENT v3.21.2

Goodwill and Other Intangible Assets (Details) $ in Thousands						1 Months Ended		12 Months Ended
	Apr. 12, 2021 USD ($)	Mar. 19, 2021 USD ($)	Feb. 14, 2020 USD ($) item product	Nov. 01, 2019 product	Mar. 19, 2019	Mar. 31, 2021 USD ($)	Jun. 30, 2018 USD ($)	Jun. 30, 2021 USD ($)	Jun. 30, 2020 USD ($)
Finite-Lived Intangible Assets [Line Items]
Impairment of intangible assets, finite-lived								$ 12,825	$ 195
Finite-lived intangible assets, net carrying amount								82,864	48,855
Amortization of intangible assets								6,009	4,490
Total amortization expense								7,100	4,500
Goodwill acquired								$ 37,712	28,090
Number of products acquired | product				4
Minimum
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, period before next renewal or extension (years)								1 year
Maximum
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, period before next renewal or extension (years)								20 years
Neos Therapeutics, Inc.
Finite-Lived Intangible Assets [Line Items]
Goodwill acquired								$ 37,700
Acquired intangible assets		$ 2,600
Acerus
Finite-Lived Intangible Assets [Line Items]
Termination agreement, aggregate amount						$ 7,500
Termination agreement, equal monthly installment payment, period						30 months
Karbinal ER
Finite-Lived Intangible Assets [Line Items]
Optional initial extension term (years)								20 years
Licensed assets
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, net carrying amount								$ 1,816	16,587
Estimated useful lives (in years)								7 years
Licensed assets | Natesto
Finite-Lived Intangible Assets [Line Items]
Impairment of intangible assets, finite-lived								$ 4,300
Finite-lived intangible assets, net carrying amount								0
Licensed assets | ZolpiMist
Finite-Lived Intangible Assets [Line Items]
Acquired intangible assets							$ 3,200
Licensed assets | ZolpiMist | Maximum
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives (in years)							7 years
Licensed assets | Tuzistra XR.
Finite-Lived Intangible Assets [Line Items]
Impairment of intangible assets, finite-lived								8,500
Product Technology Right
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, net carrying amount								41,240	21,187
Acquired intangible assets								$ 45,400
Product Technology Right | Minimum
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives (in years)								10 years
Product Technology Right | Maximum
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives (in years)								17 years
Product Technology Right | ADHD Portfolio
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives (in years)					17 years
Developed technology right
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, net carrying amount								$ 29,699
Estimated useful lives (in years)								17 years
Developed technology right | Neos Therapeutics, Inc.
Finite-Lived Intangible Assets [Line Items]
Acquired intangible assets		$ 30,200
Estimated useful lives (in years)		17 years
Product distribution rights
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, net carrying amount								$ 9,281	10,789
Product distribution rights | Minimum
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives (in years)								5 years
Product distribution rights | Maximum
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives (in years)								10 years
Product distribution rights | Innovus
Finite-Lived Intangible Assets [Line Items]
Acquired intangible assets			$ 11,400
Product distribution rights | Innovus | Minimum
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives (in years)			3 years
Product distribution rights | Innovus | Maximum
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives (in years)			10 years
Commercial technology
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, net carrying amount								$ 452
Estimated useful lives (in years)								2 years
Commercial technology | Neos Therapeutics, Inc.
Finite-Lived Intangible Assets [Line Items]
Acquired intangible assets		$ 600
Estimated useful lives (in years)		1 year
Trade name
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, net carrying amount								$ 344
Estimated useful lives (in years)								1 year
Trade name | Neos Therapeutics, Inc.
Finite-Lived Intangible Assets [Line Items]
Acquired intangible assets		$ 400
Estimated useful lives (in years)		2 years
Customer lists
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, net carrying amount								$ 32	$ 292
Estimated useful lives (in years)								1 year 6 months
Customer lists | Innovus
Finite-Lived Intangible Assets [Line Items]
Acquired intangible assets			$ 400
Estimated useful lives (in years)			1 year 6 months
Product distribution rights and customer list | Innovus
Finite-Lived Intangible Assets [Line Items]
Number of products acquired | product			35
Registered trademarks | item			300
Rumpus | In-process R&D
Finite-Lived Intangible Assets [Line Items]
Up-front fee	$ 1,500
Payment of aggregated fees	$ 600

X

- Definition

Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.

+ References

No definition available.

+ Details

Name:	aytu_AssetAcquisitionConsiderationTransferred
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Amount of consideration transferred for transaction cost incurred in asset acquisition.

+ References

No definition available.

+ Details

Name:	aytu_AssetAcquisitionConsiderationTransferredForTransactionCost
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Period before the next renewal or extension (both explicit and implicit) for intangible assets that have been renewed or extended, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	aytu_FiniteLivedIntangibleAssetPeriodBeforeNextRenewalOrExtension
Namespace Prefix:	aytu_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represents the number of products acquired.

+ References

No definition available.

+ Details

Name:	aytu_NumberOfProductsAcquired
Namespace Prefix:	aytu_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The number of trademarks and or patent rights and customer lists obtained.

+ References

No definition available.

+ Details

Name:	aytu_NumberOfRegisteredTrademarksAndOrPatentRightsAndCustomerListsAcquired
Namespace Prefix:	aytu_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Optional extension term under supply and distribution agreement.

+ References

No definition available.

+ Details

Name:	aytu_SupplyAndDistributionAgreementOptionalExtensionTerm
Namespace Prefix:	aytu_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represents aggregate amount of termination agreement.

+ References

No definition available.

+ Details

Name:	aytu_TerminationAgreementAggregateAmount
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Represents equal monthly installment payment period for termination agreement.

+ References

No definition available.

+ Details

Name:	aytu_TerminationAgreementEqualMonthlyInstallmentPaymentPeriod
Namespace Prefix:	aytu_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Total amount of amortization expense including the amount included in cost of sales.

+ References

No definition available.

+ Details

Name:	aytu_TotalAmortizationOfIntangibleAssets
Namespace Prefix:	aytu_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274

+ Details

Name:	us-gaap_AmortizationOfIntangibleAssets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

The amount of identifiable intangible assets recognized as of the acquisition date.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 55
-Paragraph 37
-URI http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472

+ Details

Name:	us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	us-gaap_FiniteLivedIntangibleAssetUsefulLife
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_FiniteLivedIntangibleAssetsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 926
-SubTopic 20
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

+ Details

Name:	us-gaap_FiniteLivedIntangibleAssetsNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

+ Details

Name:	us-gaap_GoodwillAcquiredDuringPeriod
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 3
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275

+ Details

Name:	us-gaap_ImpairmentOfIntangibleAssetsFinitelived
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_CounterpartyNameAxis=aytu_NeosTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_CounterpartyNameAxis=aytu_AcerusMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=aytu_KarbinalErMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=aytu_LicensedAssetsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=aytu_NatestoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=aytu_ZolpimistMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=aytu_TuzistraXr.Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=aytu_ProductTechnologyRightMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=aytu_AdhdPortfolioMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=aytu_ProductDistributionRightsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=aytu_InnovusPharmaceuticalsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=aytu_CommercialTechnologyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerListsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=aytu_ProductDistributionRightsAndCustomerListMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	aytu_AssetAcquisitionAxis=aytu_RumpusMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: